Home LiteratureArticle Details
PMID: 8473495 Published · ppublish English Journal Article

Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.

The Journal of clinical investigation ·Vol. 91 ·No. 4 ·1993-04-00 ·Pages 1481-9

Paliogianni F, Raptis A, Ahuja SS, Najjar SM, Boumpas DT

Abstract

IL-2 gene transcription is affected by several nuclear proteins. We asked whether dexamethasone (Dex) and cyclosporin A (CsA) inhibit IL-2 gene transcription by interfering with the activity of nuclear proteins that bind to the IL-2 promoter. Nuclear extracts from primary human T lymphocytes were analyzed by electrophoretic DNA mobility shift assays. Both Dex and CsA inhibited the binding of transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter. To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections. Jurkat cells were transfected with plasmids containing either the intact IL-2 promoter or its AP-1, NF-AT, and NF-kB motifs. Dex inhibited the IL-2 promoter and the AP-1, but not the NF-AT and NF-kB plasmids. In contrast, CsA inhibited the IL-2 promoter and the NF-AT, but not the AP-1 and NF-kB plasmids. These results suggest that in human T lymphocytes both Dex and CsA inhibited IL-2 gene transcription through interference with transcription factors AP-1 and NF-AT. We propose that, while maximum inhibition may involve interaction with both transcription factors, AP-1 is the primary target of Dex.

Related Genes
MeSH Terms
Cyclosporine/pharmacology DNA-Binding Proteins/drug effects,pharmacology Dexamethasone/pharmacology Glucocorticoids/pharmacology Humans Interleukin-2/genetics NFATC Transcription Factors Nuclear Proteins Promoter Regions, Genetic/drug effects Proto-Oncogene Proteins c-jun/drug effects,pharmacology T-Lymphocytes/physiology Transcription Factors/drug effects,pharmacology Transcription, Genetic/drug effects
Chemicals
DNA-Binding Proteins Glucocorticoids Interleukin-2 NFATC Transcription Factors Nuclear Proteins Proto-Oncogene Proteins c-jun Transcription Factors Dexamethasone Cyclosporine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Paliogianni F
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Raptis A
Ahuja S S
Najjar S M
Boumpas D T
References (41)
41 references, click to expand
  1. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
    Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214-8 PMID: 6332315
  2. A labile inhibitor blocks immunoglobulin kappa-light-chain-gene transcription in a pre-B leukemic cell line.
    Proc Natl Acad Sci U S A. 1986 Jan;83(2):295-8 PMID: 3079910
  3. Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes.
    Cell. 1986 Aug 1;46(3):401-5 PMID: 3015413
  4. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells.
    Mol Cell Biol. 1986 Sep;6(9):3042-9 PMID: 3491296
  5. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40.
    Nature. 1987 Jan 22-28;325(6102):368-72 PMID: 3027570
  6. A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor.
    J Exp Med. 1987 Feb 1;165(2):395-407 PMID: 3102668
  7. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility.
    Science. 1987 Jun 19;236(4808):1573-7 PMID: 3109035
  8. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.
    Nature. 1988 Mar 10;332(6160):166-71 PMID: 3347253
  9. Characterization of antigen receptor response elements within the interleukin-2 enhancer.
    Mol Cell Biol. 1988 Apr;8(4):1715-24 PMID: 3260003
  10. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes.
    Cell. 1988 Aug 12;54(4):541-52 PMID: 3135940
  11. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences.
    J Biol Chem. 1990 May 15;265(14):8075-80 PMID: 2159467
  12. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.
    Annu Rev Immunol. 1990;8:421-52 PMID: 2188669
  13. Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner.
    J Virol. 1990 Aug;64(8):4037-41 PMID: 2196387
  14. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.
    Cell. 1990 Sep 21;62(6):1189-204 PMID: 2169351
  15. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.
    Cell. 1990 Sep 21;62(6):1205-15 PMID: 2169352
  16. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.
    Cell. 1990 Sep 21;62(6):1217-26 PMID: 2169353
  17. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter.
    J Exp Med. 1990 Dec 1;172(6):1869-72 PMID: 1701825
  18. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.
    EMBO J. 1990 Dec;9(13):4425-33 PMID: 1702384
  19. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.
    Science. 1991 Jan 18;251(4991):313-6 PMID: 1846244
  20. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations.
    Mol Cell Biol. 1991 May;11(5):2451-9 PMID: 1901942
  21. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.
    J Clin Invest. 1991 May;87(5):1739-47 PMID: 2022743
  22. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.
    Nature. 1991 Aug 29;352(6338):803-7 PMID: 1715516
  23. Nuclear transcription factors that bind to elements of the IL-2 promoter. Induction requirements in primary human T cells.
    J Immunol. 1991 Oct 15;147(8):2734-9 PMID: 1655897
  24. Glucocorticosteroid action on the immune system: molecular and cellular aspects.
    Clin Exp Rheumatol. 1991 Jul-Aug;9(4):413-23 PMID: 1934694
  25. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40.
    Science. 1991 Oct 25;254(5031):558-62 PMID: 1683003
  26. Identification of a zinc finger protein that inhibits IL-2 gene expression.
    Science. 1991 Dec 20;254(5039):1791-4 PMID: 1840704
  27. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
    Mol Cell Biol. 1992 Feb;12(2):685-95 PMID: 1531086
  28. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.
    J Exp Med. 1992 Mar 1;175(3):637-46 PMID: 1740658
  29. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor.
    J Exp Med. 1992 May 1;175(5):1235-45 PMID: 1569395
  30. Nuclear factor of activated T cells contains Fos and Jun.
    Nature. 1992 Apr 30;356(6372):801-4 PMID: 1533441
  31. I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
    Science. 1988 Oct 28;242(4878):540-6 PMID: 3140380
  32. NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity.
    Proc Natl Acad Sci U S A. 1988 Dec;85(23):8825-9 PMID: 2848241
  33. Nuclear factors interacting with the mitogen-responsive regulatory region of the interleukin-2 gene.
    J Biol Chem. 1988 Dec 15;263(35):18904-10 PMID: 2848811
  34. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression.
    Science. 1989 Apr 28;244(4903):457-60 PMID: 2497518
  35. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes.
    EMBO J. 1989 Feb;8(2):465-73 PMID: 2542017
  36. Characterization of junD: a new member of the jun proto-oncogene family.
    EMBO J. 1989 May;8(5):1433-9 PMID: 2504580
  37. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation.
    Science. 1989 Dec 22;246(4937):1617-20 PMID: 2595372
  38. Corticosteroids and lymphoid cells.
    N Engl J Med. 1972 Aug 24;287(8):388-97 PMID: 5043524
  39. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  40. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  41. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1993-04-00
Pages
1481-9
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC288123
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]